½ÃÀ庸°í¼­
»óǰÄÚµå
1701958

ÀÇ·á¿ë 꺿 ½ÃÀå : ±¸¼º¿ä¼Òº°, Àü°³ ¹æ½Äº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Healthcare Chatbots Market Report by Component, Deployment Mode, Application, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 142 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë 꺿 ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 3¾ï 5,250¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 14¾ï 380¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025³âºÎÅÍ 2033³â±îÁö 16.6%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ µðÁöÅÐ ±â¼ú äÅà Ȯ´ë, COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ÀÚ¿¬¾î ó¸®ÀÇ ¹ßÀü, ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø, 24½Ã°£ 365ÀÏ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀ» ¹è°æÀ¸·Î ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë 꺿 ½ÃÀå ºÐ¼®:

½ÃÀå ¼ºÀå°ú ±Ô¸ð : ¼¼°è ÀÇ·á¿ë 꺿 ½ÃÀåÀº µðÁöÅÐ ±â¼úÀÇ ÅëÇÕ, COVID-19ÀÇ ¿µÇâ, ºñ¿ë È¿À²¼º¿¡ ´ëÇÑ ¿ä±¸ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¾ÕÀ¸·Îµµ Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ : ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ µðÁöÅÐ ±â¼ú äÅÃ, ÆÒµ¥¹ÍÀÇ ¿µÇâ, ºñ¿ë È¿À²¼º °í·Á, ¸¸¼ºÁúȯ Áõ°¡, ÀΰøÁö´É(AI) ¹× ÀÚ¿¬¾î ó¸®(NLP) ¹ßÀü, ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø, ȯÀÚ ÀÎ½Ä Áõ°¡, 24½Ã°£ 365ÀÏ ÀÇ·á ¼­ºñ½ºÀÇ Çʿ伺 µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀü : ÀÚ¿¬¾î ó¸®(NLP), ¸Ó½Å·¯´×(ML), ÀΰøÁö´É(AI) ¾Ë°í¸®ÁòÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀº Á¤È®ÇÑ Áø´Ü, °³ÀÎÈ­µÈ Ä¡·á Á¦¾È, ȯÀÚ¿ÍÀÇ ´ëÈ­ °³¼±À» Áö¿øÇÏ´Â ÀÇ·á¿ë 꺿ÀÇ ±â´ÉÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

»ê¾÷ ¾ÖÇø®ÄÉÀÌ¼Ç : ÀÇ·á¿ë 꺿Àº Áõ»ó È®ÀÎ, ¿¹¾à, Åõ¾à ¾Ë¸², Ä¡·á ÈÄ ÈÄ¼Ó Á¶Ä¡ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Æø³Ð°Ô Àû¿ëµÇ¾î ȯÀÚ Âü¿©¿Í ¼øÀÀµµ Çâ»ó¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : ÁÖ¸ñÇÒ ¸¸ÇÑ µ¿ÇâÀ¸·Î´Â Áõ»ó Æò°¡, ¿¹¾à ½ºÄÉÁÙ¸µ, °Ç°­ Á¤º¸ Àü´Þ¿¡ ÀÖ¾î 꺿ÀÇ È°¿ë È®´ë°¡ ²ÅÈü´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¿¬±¸ ¹× µ¥ÀÌÅÍ ¼öÁý¿¡¼­ 꺿ÀÇ ¿ªÇÒÀÌ Á¡Á¡ ´õ Áß¿äÇÏ°Ô Àνĵǰí ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : ÀÇ·á¿ë 꺿 µµÀÔÀº Àü ¼¼°èÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç, ºÏ¹Ì¿Í À¯·´ µîÀÇ Áö¿ªÀº ¼º¼÷ÇÑ ÀÇ·á Á¦µµ¿Í ±ÔÁ¦ Áö¿øÀ¸·Î 꺿 µµÀÔÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù.

°æÀï ȯ°æ : ÀÌ ½ÃÀåÀº 꺿 ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ´Ù¼öÀÇ ±â¾÷µéÀÌ °æÀïÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº ½ÃÀå Á¶»ç ¹× ÄÁ¼³ÆÃ ¼­ºñ½º¿¡¼­ ½ÃÀå ¸®´õ ¹× Àü¹®°¡·Î ÀÚ¸®¸Å±èÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

µµÀü°ú ±âȸ : µµÀü°úÁ¦·Î´Â ÀÇ·á ±ÔÁ¦ÀÇ ¾ö°ÝÇÑ Áؼö, ȯÀÚ µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È º¸Àå µîÀÌ ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ´Â 꺿 ±â´ÉÀÇ Áö¼ÓÀûÀÎ Çõ½Å°ú ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ È°¿ë È®´ë¿¡ ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë 꺿 ½ÃÀå µ¿Çâ:

ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ µðÁöÅÐ ±â¼ú ÅëÇÕ

ÀÇ·á ºÐ¾ß¿¡ µðÁöÅÐ ±â¼úÀÇ ÅëÇÕÀº ¼¼°è ÀÇ·á¿ë 꺿 ½ÃÀåÀÇ ¸Å¿ì Áß¿äÇÑ ¿øµ¿·ÂÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº Á¡Á¡ ´õ µðÁöÅÐÈ­¸¦ ¹Þ¾ÆµéÀ̰í ÀÖÀ¸¸ç, ȯÀÚ Âü¿©¸¦ °­È­Çϰí ÀÇ·á ¼­ºñ½º¸¦ °£¼ÒÈ­ÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. 꺿Àº ȯÀÚ°¡ ÀÇ·áÁø°ú ¼ÒÅëÇϰí, Á¤º¸¿¡ Á¢±ÙÇϰí, °³ÀÎÈ­µÈ ÃßõÀ» ¹ÞÀ» ¼ö ÀÖ´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º¸¦ Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ȯÀÚ °æÇèÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á ¾÷¹«ÀÇ ÃÖÀûÈ­¿¡µµ µµ¿òÀÌ µË´Ï´Ù. 꺿À» Ȱ¿ëÇϸé ÀÇ·á ±â°üÀº ¿¹¾àÀ» È¿À²ÀûÀ¸·Î °ü¸®Çϰí, °Ç°­ Á¤º¸¸¦ Àü´ÞÇϰí, ȯÀÚ¿¡°Ô Àû½Ã¿¡ Áö¿øÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ:

COVID-19 »çÅ´ ÀÇ·á¿ë 꺿¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. »çȸÀû °Å¸®µÎ±â·Î ÀÎÇØ ¿ø°ÝÀ¸·Î ÀÇ·á ¼­ºñ½º¸¦ ¹Þ¾Æ¾ß ÇÒ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ 꺿Àº Áõ»ó Æò°¡, COVID-19 Á¤º¸ Àü´Þ, ¿¹¾à ½ºÄÉÁÙ¸µ µîÀ» À§ÇÑ ±ÍÁßÇÑ µµ±¸·Î µîÀåÇß½À´Ï´Ù. ÀÇ·á½Ã¼³Àº ´Ã¾î³ª´Â ¹®ÀǸ¦ È¿À²ÀûÀ¸·Î ó¸®Çϱâ À§ÇØ Ãªº¿¿¡ ÁÖ¸ñÇϰí ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ÀÇ·áÁøÀÌ Áß¿äÇÑ È¯ÀÚ Áø·á¿¡ ÁýÁßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ´Â Àû½Ã¿¡ Á¤È®ÇÑ Á¤º¸¸¦ Á¦°øÇϴ êº¿ÀÇ Á߿伺À» ºÎ°¢½ÃÄ×À» »Ó¸¸ ¾Æ´Ï¶ó, À§±â °ü¸® ¹× ÀÇ·á ÀÚ¿ø ¹èºÐ¿¡ À־µµ 꺿ÀÇ È¿°ú¸¦ ÀÔÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½ºÀÇ Çʼö ¿ä¼Ò·Î¼­ ÀÇ·á¿ë 꺿ÀÌ ÆÒµ¥¹Í ±â°£ µ¿¾È ÀÇ·á¿ë 꺿ÀÌ ±¤¹üÀ§ÇÏ°Ô Ã¤ÅÃµÈ °Íµµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·áÀÇ ºñ¿ë È¿À²È­:

ÀÇ·á ºñ¿ëÀÇ »ó½ÂÀº ¿À·£ ±â°£ µ¿¾È ¿ì·ÁµÇ¾î ¿ÔÀ¸¸ç, ÀÇ·á¿ë 꺿Àº ÀÌ ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ´Â ½ÇÇà °¡´ÉÇÑ ¼Ö·ç¼ÇÀ¸·Î ¿©°ÜÁö°í ÀÖ½À´Ï´Ù. 꺿À» µµÀÔÇϸé ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ¿î¿µ ºñ¿ëÀ» Å©°Ô Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¾à ¿¹¾à, º¸Çè È®ÀÎ, û±¸ ¹®ÀÇ µî ÀÏ»óÀûÀÎ °ü¸® ¾÷¹«¸¦ ó¸®ÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÇ·áÁøÀº º¸´Ù º¹ÀâÇϰí Àü¹®ÀûÀÎ ¾÷¹«¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î¼¼½º¸¦ ÀÚµ¿È­ÇÔÀ¸·Î½á ÀÇ·á ±â°üÀº ÀÚ¿ø ¹èºÐÀ» ÃÖÀûÈ­Çϰí Àü¹ÝÀûÀÎ ºñ¿ë È¿À²¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ë Àý°¨ °¡´É¼ºÀº ÀÇ·á ÀÇ»ç°áÁ¤±ÇÀÚµéÀÇ °ü½ÉÀ» ²ø°í ÀÖÀ¸¸ç, ȯÀÚ Ä¡·áÀÇ ÁúÀ» À¯ÁöÇϸ鼭 ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â Àü·«Àû µµ±¸·Î 꺿À» äÅÃÇϰí ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ÀÇ·á¿ë 꺿ÀÇ ºñ¿ë È¿À²¼ºÀº Àü ¼¼°è ÀÇ·á ºÐ¾ß¿¡¼­ 꺿À» ±¤¹üÀ§ÇÏ°Ô Ã¤ÅÃÇÏ´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù:

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× ¿ø°ÝÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÇ·á¿ë 꺿 ½ÃÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÁַΠȯÀÚ Áß½ÉÀÇ ±â¼ú ´ëÀÀ ¸ðµ¨·Î ÀÇ·á ÆÐ·¯´ÙÀÓÀÌ º¯È­ÇÔ¿¡ µû¶ó ¹ß»ýÇÕ´Ï´Ù. ¸¸¼ºÁúȯÀÇ Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ ÀüÅëÀûÀÎ ÀÇ·á ȯ°æ ¹Û¿¡¼­ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú °Ç°­ »óÅ °ü¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ÀÇ·á¿ë 꺿 ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : ±¸¼º¿ä¼Òº°

  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦7Àå ½ÃÀå ³»¿ª : Àü°³ ¹æ½Äº°

  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º

Á¦8Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • Áõ»ó üũ
  • ÇコÄɾÀǾàǰ Á¤º¸ Áö¿ø
  • ¿¹¾à ½ºÄÉÁÙ¸µ¡¤°¨½Ã
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • ȯÀÚ
  • ÀÇ·á Á¦°øÀÚ
  • º¸Çèȸ»ç
  • ±âŸ

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå ³»¿ª : ±¹°¡º°

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Ada Health GmbH
    • Babylon Inc.
    • Buoy Health Inc.
    • Creative Virtual Ltd.
    • GYANT.com Inc.
    • HealthTap Inc.
    • Infermedica
    • Microsoft Corporation
    • PACT Care BV
    • Sensely Inc.
    • Woebot Health
    • Your.MD Ltd.
ksm 25.05.19

The global healthcare chatbots market size reached USD 352.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,403.8 Million by 2033, exhibiting a growth rate (CAGR) of 16.6% during 2025-2033. The market is witnessing steady growth driven by the growing adoption of digital technologies in healthcare, the impact of the COVID-19 pandemic, rising prevalence of chronic diseases, advancements in natural language processing, regulatory support for telehealth, and increasing demand for 24/7 healthcare.

Healthcare Chatbots Market Analysis:

Market Growth and Size: The global healthcare chatbots market is experiencing robust growth, driven by factors, such as digital technology integration, the impact of COVID-19, and cost-efficiency demands. It is expected to continue expanding significantly over the coming years.

Major Market Drivers: Key drivers include the adoption of digital tech in healthcare, the pandemic's influence, cost-efficiency considerations, the rise in chronic diseases, advancements in artificial intelligence (AI) and natural language processing (NLP), regulatory support, growing patient awareness, and the need for 24/7 healthcare services.

Technological Advancements: Rapid technological advancements in natural language processing (NLP), machine learning (ML), and artificial intelligence (AI) algorithms have significantly enhanced the capabilities of healthcare chatbots which assists in accurate diagnosis, personalized treatment recommendations, and improved patient interactions.

Industry Applications: Healthcare chatbots find extensive applications across various domains, including symptom checking, appointment scheduling, medication reminders, and post-treatment follow-ups, contributing to improved patient engagement and adherence.

Key Market Trends: Notable trends include the increased use of chatbots for symptom assessment, appointment scheduling, and health information dissemination. Additionally, chatbots are increasingly recognized for their role in medical research and data collection.

Geographical Trends: The adoption of healthcare chatbots is growing globally, with regions like North America and Europe leading in implementation due to their mature healthcare systems and regulatory support.

Competitive Landscape: The market features a competitive landscape with numerous players offering chatbot solutions. Leading companies are striving to establish themselves as thought leaders and experts in market research and consulting services.

Challenges and Opportunities: Challenges include the need for strict compliance with healthcare regulations and ensuring the privacy and security of patient data. Opportunities lie in the continuous innovation of chatbot capabilities and the expansion of their use across various healthcare applications.

Healthcare Chatbots Market Trends:

Integration of digital technology in healthcare

The integration of digital technologies into the healthcare sector is a pivotal driver of the global healthcare chatbots market. As healthcare providers increasingly embrace digitalization, they seek innovative solutions to enhance patient engagement and streamline healthcare services. Chatbots play a vital role in achieving these objectives by providing a user-friendly interface for patients to interact with healthcare providers, access information, and even receive personalized recommendations. This integration not only improves patient experience but also optimizes healthcare operations. By leveraging chatbots, healthcare organizations can efficiently manage appointments, disseminate health information, and offer timely support to patients.

Impact of the COVID-19 pandemic:

The COVID-19 pandemic has accelerated the demand for healthcare chatbots significantly. With the need for social distancing and remote healthcare services, chatbots have emerged as a valuable tool for symptom assessment, COVID-19 information dissemination, and appointment scheduling. Healthcare facilities have turned to chatbots to efficiently handle the increased volume of inquiries, allowing human healthcare staff to focus on critical patient care, which has not only highlighted the importance of chatbots in providing timely and accurate information but has also demonstrated their effectiveness in crisis management and healthcare resource allocation. Further, the widespread adoption of healthcare chatbots during the pandemic as an essential component of healthcare services, is supporting the market growth.

Cost-efficiency in healthcare:

Rising healthcare costs have been a longstanding concern, and healthcare chatbots are seen as a viable solution to address this issue. The implementation of chatbots can significantly reduce operational expenses for healthcare providers. They can handle routine administrative tasks such as appointment scheduling, insurance verification, and billing inquiries, freeing up healthcare personnel to focus on more complex and specialized tasks. By automating these processes, healthcare organizations can optimize resource allocation and improve overall cost efficiency. This cost-saving potential has garnered the attention of healthcare decision-makers, who are increasingly adopting chatbots as a strategic tool to contain expenses while maintaining the quality of patient care. Consequently, the cost-effectiveness of healthcare chatbots is a driving force behind their widespread adoption in the global healthcare sector.

Rising need for remote patient monitoring and telehealth solutions:

The rising need for remote patient monitoring and telehealth solutions is a key factor propelling the healthcare chatbots market. This trend is primarily driven by the paradigm shift in healthcare towards more patient-centric, technology-enabled models. The increasing prevalence of chronic diseases and the aging population have heightened the demand for continuous monitoring and management of health conditions outside traditional healthcare settings.

Healthcare Chatbots Industry Segmentation:

Breakup by Component:

  • Software
  • Services

Software accounts for the majority of the market share

Breakup by Deployment Mode:

  • Cloud-based
  • On-premises

Cloud-based holds the largest share in the industry

Breakup by Application:

  • Symptoms Check
  • Medical and Drug Information Assistance
  • Appointment Scheduling and Monitoring
  • Others

Symptoms check represents the leading market segment

Breakup by End User:

  • Patients
  • Healthcare Providers
  • Insurance Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest healthcare chatbots market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Ada Health GmbH
  • Babylon Inc.
  • Buoy Health Inc.
  • Creative Virtual Ltd.
  • GYANT.com Inc.
  • HealthTap Inc.
  • Infermedica
  • Microsoft Corporation
  • PACT Care BV
  • Sensely Inc.
  • Woebot Health
  • Your.MD Ltd.

Key Questions Answered in This Report

  • 1.What was the size of the global healthcare chatbots market in 2024?
  • 2.What is the expected growth rate of the global healthcare chatbots market during 2025-2033?
  • 3.What are the key factors driving the global healthcare chatbots market?
  • 4.What has been the impact of COVID-19 on the global healthcare chatbots market?
  • 5.What is the breakup of the global healthcare chatbots market based on the component?
  • 6.What is the breakup of the global healthcare chatbots market based on the deployment mode?
  • 7.What is the breakup of the global healthcare chatbots market based on the application?
  • 8.What are the key regions in the global healthcare chatbots market?
  • 9.Who are the key players/companies in the global healthcare chatbots market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Healthcare Chatbots Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Mode

  • 7.1 Cloud-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 On-premises
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Symptoms Check
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical and Drug Information Assistance
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Appointment Scheduling and Monitoring
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Patients
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Healthcare Providers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Insurance Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Ada Health GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Babylon Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Buoy Health Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Creative Virtual Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GYANT.com Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 HealthTap Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Infermedica
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Microsoft Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PACT Care BV
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sensely Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Woebot Health
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Your.MD Ltd.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦